Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BUFFALO, NY--(Marketwired - Jul 12, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that Board Chair Richard McGowan and Audit Committee Chair James Antal resigned from the company's...
-
BUFFALO, NY--(Marketwired - May 16, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2016. ...
-
BUFFALO, NY--(Marketwired - Apr 4, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will webcast its 2016 Annual Meeting of Stockholders on April 14, 2016 at its...
-
BUFFALO, NY--(Marketwired - Mar 16, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced an update on the regulatory review of its pre-Emergency Use Authorization (pre-EUA) submission for...
-
BUFFALO, NY--(Marketwired - Feb 22, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and year ended December 31, 2015....
-
BUFFALO, NY--(Marketwired - Feb 9, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Roswell Park Cancer Institute (RPCI) today announced the publication of studies elucidating immunotherapeutic...
-
BUFFALO, NY--(Marketwired - Feb 2, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the initiation of a Phase 2, single-blind, randomized, placebo-controlled clinical study of the...
-
BUFFALO, NY--(Marketwired - Jan 26, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the start of dosing in a Phase 2, randomized, placebo-controlled clinical study of CBLB612 as...
-
BUFFALO, NY--(Marketwired - Jan 21, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI), today announced that entolimod has been granted orphan drug status by the European Medicines Agency (EMA) for...
-
BUFFALO, NY--(Marketwired - Dec 22, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that through a series of transactions and in cooperation with Open Joint Stock Company RUSNANO...